Keeping Track: Axsome’s Auvelity Survives Long Review; Bluebird’s Zynteglo Cleared For Liftoff; Omeros Appeals CRL

 
• By Bridget Silverman

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

Keeping Track Feature image
Latest FDA approvals include Auvelity, a rapid-acting oral treatment for depressive symptoms.

More from US FDA Performance Tracker

More from Regulatory Trackers